Ignite Creation Date:
2024-05-06 @ 3:52 AM
Last Modification Date:
2024-10-26 @ 11:40 AM
Study NCT ID:
NCT02391727
Status:
COMPLETED
Last Update Posted:
2018-11-16
First Post:
2015-03-09
Brief Title:
Safety Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid Tumors
Sponsor:
Synermore Biologics Co Ltd
Organization:
Synermore Biologics Co Ltd
Organization Data
Organization:
Synermore Biologics Co Ltd
Class:
INDUSTRY
Study ID:
SYN004-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Synermore Biologics Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None